These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

580 related items for PubMed ID: 25886657

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
    Loy JH, Merry SN, Hetrick SE, Stasiak K.
    Cochrane Database Syst Rev; 2012 Sep 12; (9):CD008559. PubMed ID: 22972123
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ.
    Aman MG, Binder C, Turgay A.
    J Child Adolesc Psychopharmacol; 2004 Sep 12; 14(2):243-54. PubMed ID: 15319021
    [Abstract] [Full Text] [Related]

  • 8. Callous-unemotional traits, proactive aggression, and treatment outcomes of aggressive children with attention-deficit/hyperactivity disorder.
    Blader JC, Pliszka SR, Kafantaris V, Foley CA, Crowell JA, Carlson GA, Sauder CL, Margulies DM, Sinha C, Sverd J, Matthews TL, Bailey BY, Daviss WB.
    J Am Acad Child Adolesc Psychiatry; 2013 Dec 12; 52(12):1281-93. PubMed ID: 24290461
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Aggression and disruptive behavior disorders in children and adolescents.
    Turgay A.
    Expert Rev Neurother; 2004 Jul 12; 4(4):623-32. PubMed ID: 15853581
    [Abstract] [Full Text] [Related]

  • 13. Combination use of atomoxetine hydrochloride and olanzapine in the treatment of attention-deficit/hyperactivity disorder with comorbid disruptive behavior disorder in children and adolescents 10-18 years of age.
    Holzer B, Lopes V, Lehman R.
    J Child Adolesc Psychopharmacol; 2013 Aug 12; 23(6):415-8. PubMed ID: 23952189
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Treatment of comorbidity in conduct disorder with attention-deficit hyperactivity disorder (ADHD).
    Turgay A.
    Essent Psychopharmacol; 2005 Aug 12; 6(5):277-90. PubMed ID: 16222912
    [Abstract] [Full Text] [Related]

  • 18. Risperidone added to parent training and stimulant medication: effects on attention-deficit/hyperactivity disorder, oppositional defiant disorder, conduct disorder, and peer aggression.
    Gadow KD, Arnold LE, Molina BS, Findling RL, Bukstein OG, Brown NV, McNamara NK, Rundberg-Rivera EV, Li X, Kipp HL, Schneider J, Farmer CA, Baker JL, Sprafkin J, Rice RR, Bangalore SS, Butter EM, Buchan-Page KA, Hurt EA, Austin AB, Grondhuis SN, Aman MG.
    J Am Acad Child Adolesc Psychiatry; 2014 Sep 12; 53(9):948-959.e1. PubMed ID: 25151418
    [Abstract] [Full Text] [Related]

  • 19. ADHD with comorbid oppositional defiant disorder or conduct disorder: discrete or nondistinct disruptive behavior disorders?
    Connor DF, Doerfler LA.
    J Atten Disord; 2008 Sep 12; 12(2):126-34. PubMed ID: 17934178
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.